Shanghai Pharmaceuticals (601607.SH): Omeprazole Sodium Bicarbonate Dry Suspension (I) has been approved for production.

Zhito Finance APP News, Shanghai Pharmaceutical (601607.SH) announced that recently, its subsidiary Shanghai Shyuyou Xinyi Pharmaceutical Co., Ltd. (referred to as "Shyuyou Xinyi") received the "Drug Registration Certificate" (Certificate No.: 2026S02750) issued by the National Medical Products Administration for Omeprazole Sodium Bicarbonate Dry Suspension (I), and the drug has been approved for production.